Clinicopathologic Features and Survival of Breast Cancer Subtypes in Northeast Iran

  • سال انتشار: 1397
  • محل انتشار: مجله سرطان خاورمیانه، دوره: 9، شماره: 1
  • کد COI اختصاصی: JR_MISJ-9-1_005
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 207
دانلود فایل این مقاله

نویسندگان

Soodabeh Shahidsales

Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mona Joudi

Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Marjaneh Mirsadraee

Reza Radiotherapy Oncology Center, Mashhad, Iran

Amir Avan

Molecular Medicine Group, Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Saeideh Ahmadi Simab

Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad-Reza Ghavamnasiri

Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

چکیده

Background: Breast cancer can be categorized into different histopathological subtypes based on gene expression profiles. The aim of this study was to evaluate the clinicopathological features and overall survival (OS) of various subtypes of breast cancer in order to help diagnosis and guide treatment. Method: The clinicopathologic features of ۱۰۹۵ patients with breast cancer diagnosed over a ۱۰–year period between ۲۰۰۱ and ۲۰۱۱were analyzed. Kaplan–Meier method was used to analyze the disease-free survival (DFS) and overall survival (OS). Calculation of hazard ratio (HR) was conducted by multivariate Cox regression.Results: According to the clinicopathologic characteristics of ۱۰۹۵ cases, ۴۲% were luminal A subtype, ۱۹.۲% luminal B, ۲۳% triple negative and ۱۵% Her-۲+. The lowest (۴۶.۸۸±۱۲.۵۹ years) and highest (۵۰.۵۴±۱۲.۳۲ years) mean age were in triple negative and Her۲+ groups, respectively. There was a significant correlation between histology subtype and age, BMI, lymph node, type of surgery, and stage of disease. Overall survival (OS) and disease free survival (DFS) were significantly shorter in Her-۲+ breast cancer patients (P< ۰.۰۰۱). Multivariate analysis showed that age had the highest hazard ratio of ۲.۴۸۱(CI ۱.۳۷۵- ۴.۴۷۷).Conclusion: The results of this study showed the importance of clinicopathological studies of molecular types which helps early diagnosis and identification of best strategy to treat the disease.

کلیدواژه ها

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.